We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nasal Spray Provides Rapid Pain Relief for Children in Emergency Care

By HospiMedica International staff writers
Posted on 30 Sep 2026

Pain in children treated in emergency departments can be difficult to control quickly, and inadequate analgesia may increase distress for both patients and families during urgent care. More...

Treatment options can be limited, while some approaches require injections that may add further discomfort. A new study now shows that a nasal spray treatment may provide rapid, needle-free pain relief for pediatric emergency patients.

The research was conducted through Sheffield Children’s Hospital, the University of Sheffield, and Sheffield Hallam University in the UK. The study evaluated a nasal spray combining two analgesic medications, sufentanil and ketamine, with dosing adjusted to each child’s weight by varying the number of sprays administered. The approach was designed to provide a simple, weight-based dosing system for children experiencing moderate to severe pain.

The study included 152 children ages one to 17 years who were treated at seven hospital emergency departments in the UK and Spain between May 2024 and May 2025. Most children had limb injuries, including fractures and dislocations. Other participants had burns or soft tissue injuries. Pain levels and side effects were assessed at 15 minutes and 30 minutes after treatment using standard assessments.

The findings were presented at the European Emergency Medicine Congress (EUSEM 2026). After 15 minutes, 54% of children had less pain. After 30 minutes, 88% had less pain, and pain was reduced by around half in 86.2% of children. Reported side effects were mild and included nausea or vomiting, dizziness and nasal itching.

The nasal spray was tested for the European Medicines Agency pediatric-use marketing authorization scheme, which is intended to encourage manufacturers to develop and adapt medications specifically for children. The treatment is expected to become available for use in Europe in the near future.

“Our research shows that this drug can provide rapid and meaningful pain relief for children being treated in the emergency department. Children tolerated the nose spray well with no major side effects. This is good news for children and their families. This also gives doctors a simple and effective option for treating their patients where very few options currently exist,” said Shammi Ramlakhan, an emergency medicine consultant working at Sheffield Children’s Hospital, the University of Sheffield and Sheffield Hallam University in the UK.

Related Links
University of Sheffield
Sheffield Hallam University


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Multi-Chamber Washer-Disinfector
WD 390
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.